Loading ......
Zodasiran is an RNA interference (RNAi) therapeutic that inhibits ANGPTL3 expression and reduces atherogenic lipoproteins through mechanisms independent of the LDL receptor (LDLR). It is a promising therapy for hyperlipidemia, familial hypercholesterolemia or moderate-to-severe hypertriglyceridemia.
Chemical Structure:

Loading ......